Andrews William T. reported option exercise involving 3,052 derivative units of CATALYST PHARMACEUTICALS, INC. at $0.00 for $0 on Jun 3, 2025

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Medical Officer
Chief Medical Officer
Filed Jun 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
3,052Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
240,195Direct
Trade date
Jun 3, 2025Option exercise
Filed
Jun 5, 2026, 5:00 PM ET367-day reporting delay
Accession
0001161697-26-000132Code M · Transaction 99504
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 3, 2026Option exercise3,052——Trade 99502
Jun 3, 2026Tax withholding743——Trade 99503
3 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 367 calendar days after the transaction date.

CPRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CPRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Jun 12, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. F2: Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock. F3: Derivative securities vest in equal tranches, 1/5th each on June 2, 2026, 2027, 2028, 2029, and 2030. F4: Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on June 3, 2026.